Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDK19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | KLF12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SUSD6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | PCDHA4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PDE7A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | CCDC102A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | PCDHA6 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | STAMBPL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | NUP37 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |